Topic: Implementation of innovative approaches to achieve Proof-of-Concept results in record time in Early Phase Clinical Trials? With close to two decades of professional experience in Healthcare and Biotechnology, Dr. Singh is evidenced to be a consummate professional. Dr. Singh received his MD on a full-ride scholarship from Govt’ Medical College, India — and a Master’s in Health Administration with MBA Finance Electives from the University of Southern California, Los Angeles. Besides previous experience as a practising Primary Care Physician, Dr. Singh served as the Chief Medical Officer for Los Angeles based Clear Protocol, Inc., an Augmented Reality Google- Glass Medical Technology Startup deploying CMS mandated checklists in Medicine and Surgery.  His repertoire of other roles include Chief Medical Advisor for WeHeal Foundation presently– besides Medical Advisory Board for Exosomics Inc, Medical Advisory Board for PrognosDx Health, Senior Corporate Ambassador for Relamatrix Group Inc. etc.  His areas of expertise are in Molecule Discovery Lifecycle (including Clinical Development), Regulatory Interactions, Stewardship of Clinical Science Teams, Pharmacovigilance, Molecular Diagnostics, Liquid Onco-Biopsy, Product Development Phase Protocol Review, and Medical Affairs Strategy & Logistics. For Healthcare, his specialties include, but are not limited to: Providers, Payors, Pharma Engagement, Continuum of Care Strategy & Operations, Patient Experience, Brand Architecture, Health Information Technology, and Corporate Consulting.